Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $1.76 Million - $2.02 Million
12,153 Added 16.02%
88,026 $14 Billion
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $10.5 Million - $12.6 Million
75,873 New
75,873 $12.3 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Boone Capital Management LLC Portfolio

Follow Boone Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boone Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boone Capital Management LLC with notifications on news.